Exelead
Tracey Froggatt is a seasoned professional in quality assurance and pharmaceutical research, currently serving as a Sr. Quality Assurance Auditor at Exelead since June 2016, where Tracey focuses on the qualification of suppliers and ensures adherence to regulatory guidelines. Prior experience includes a role as a Quality Assurance Auditor at Dow AgroSciences from September 2009 to June 2016, responsible for data review and inspections to validate scientific reports. Earlier in Tracey’s career, a position as a Research Scientist at AstraZeneca involved designing and developing experiments aimed at supporting coronary artery disease research. Tracey holds a Bachelor of Science degree in Cell/Cellular and Molecular Biology from The Manchester Metropolitan University and received education at Cheadle Hulme High School in the U.K.
This person is not in any teams
Exelead
Scientists are driven by powerful ideas to develop innovative molecules that can save lives. But to bring their drug to market, they must navigate pharmaceutical manufacturing, clinical trials, logistical complexities and strict regulations. Exelead guides you through each step, so you can get your drug to patients that need it. Exelead specializes in manufacturing lipid nanoparticle, liposome, and pegylated formulations. We work with you to bring your drug from development to commercialization. The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors. Learn more: https://www.sigmaaldrich.com/US/en/collections/press/closing-of-exelead-acquisition